AstraZeneca PLC (AZN)
156.90
-0.80
(-0.51%)
USD |
NYSE |
Oct 02, 16:00
157.01
+0.11
(+0.07%)
After-Hours: 20:00
AstraZeneca Price : 156.90 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 158.46 | 158.80 | 156.41 | 156.90 | 3.036M |
| Oct 01, 2026 | 160.77 | 161.32 | 157.54 | 157.70 | 3.378M |
| Sep 30, 2026 | 164.47 | 164.48 | 161.46 | 161.47 | 2.225M |
| Sep 29, 2026 | 165.09 | 166.46 | 163.24 | 164.21 | 3.372M |
| Sep 28, 2026 | 165.69 | 167.52 | 165.39 | 166.15 | 1.727M |
| Sep 25, 2026 | 166.16 | 166.81 | 164.60 | 166.58 | 2.068M |
| Sep 24, 2026 | 162.91 | 166.25 | 162.91 | 164.56 | 3.189M |
| Sep 23, 2026 | 166.58 | 167.59 | 163.33 | 163.33 | 2.361M |
| Sep 22, 2026 | 167.84 | 169.35 | 166.74 | 168.37 | 2.306M |
| Sep 21, 2026 | 168.45 | 169.00 | 167.11 | 168.10 | 2.938M |
| Sep 18, 2026 | 167.15 | 167.83 | 165.54 | 166.08 | 3.060M |
| Sep 17, 2026 | 164.59 | 166.29 | 164.30 | 166.14 | 3.808M |
| Sep 16, 2026 | 164.21 | 165.42 | 162.02 | 162.89 | 3.859M |
| Sep 15, 2026 | 161.42 | 163.90 | 160.71 | 161.85 | 2.939M |
| Sep 14, 2026 | 164.08 | 164.55 | 162.14 | 163.78 | 3.094M |
| Sep 11, 2026 | 161.43 | 161.51 | 158.13 | 160.17 | 2.229M |
| Sep 10, 2026 | 157.68 | 160.30 | 157.23 | 159.64 | 2.935M |
| Sep 09, 2026 | 158.31 | 159.13 | 156.74 | 156.94 | 3.874M |
| Sep 08, 2026 | 163.96 | 163.96 | 159.40 | 160.04 | 5.146M |
| Sep 04, 2026 | 162.82 | 163.78 | 161.13 | 162.70 | 3.073M |
| Sep 03, 2026 | 165.64 | 165.74 | 162.24 | 164.77 | 2.425M |
| Sep 02, 2026 | 162.54 | 164.69 | 160.87 | 161.63 | 3.301M |
| Sep 01, 2026 | 163.66 | 164.24 | 161.38 | 162.47 | 2.598M |
| Aug 31, 2026 | 162.70 | 163.75 | 161.95 | 162.13 | 3.068M |
| Aug 28, 2026 | 163.52 | 163.54 | 161.18 | 162.70 | 2.881M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| GSK Plc | 47.03 |
| Johnson & Johnson | 256.03 |
| Eli Lilly & Co. | 1142.85 |
| Merck & Co., Inc. | 144.30 |
| Novo Nordisk A/S | 37.32 |
Price Related Metrics
| PS Ratio | 8.100 |
| PEG Ratio | 1.386 |
| Price to Book Value | 10.28 |
| Price to Free Cash Flow | 60.84 |
| Earnings Yield | 2.12% |
| Market Cap | 486.65B |
| PEGY Ratio | 1.307 |
| Operating PE Ratio | 34.87 |
| Normalized PE Ratio | 46.58 |